Table 3.
Clinical characteristics of patients in ESCC datasets.
Characteristic | ESCC-train | ESCC-test | P | ESCC-valid | P |
---|---|---|---|---|---|
NO. of samples | 60 | 59 | 60 | ||
Age (median) | 59 | 59 | 0.8564* | 60.23973 | 0.6180* |
Gender | 0.6610 | 1 | |||
Male | 48 | 50 | 48 | ||
Female | 12 | 9 | 12 | ||
Smoke | 0.1340 | 0.8531 | |||
Yes | 36 | 44 | 34 | ||
No | 24 | 15 | 26 | ||
Alcohol | 0.7591 | 0.5805 | |||
Yes | 36 | 38 | 32 | ||
No | 24 | 21 | 28 | ||
Tumour location | 0.4270 | 0.1031 | |||
Upper | 7 | 7 | 6 | ||
Middle | 38 | 31 | 28 | ||
Lower | 15 | 21 | 26 | ||
Tumour grade | 0.1966 | 0.2891 | |||
Well differntiated | 16 | 8 | 9 | ||
Moderately differentiated | 29 | 35 | 34 | ||
Poorly differentiated | 15 | 16 | 17 | ||
T stage | 0.6019 | 0.0002 | |||
T1 | 3 | 5 | 4 | ||
T2 | 12 | 8 | 7 | ||
T3 | 29 | 33 | 48 | ||
T4 | 16 | 13 | 1 | ||
N stage | 0.1938 | 0.6360 | |||
N0 | 24 | 30 | 29 | ||
N1 | 26 | 16 | 20 | ||
N2 | 7 | 6 | 9 | ||
N3 | 3 | 7 | 2 | ||
TNM stage | 0.2333 | 0.1900 | |||
I | 1 | 5 | 4 | ||
II | 25 | 22 | 30 | ||
III | 34 | 32 | 26 | ||
Death at follow-up | 1 | 0.5786 | |||
Yes | 37 | 36 | 33 | ||
No | 23 | 23 | 27 | ||
Median survival (months) | 31.9833 | 32.2 | 0.9576* | 39.3333 | 0.1825* |
P-Values are calculated by χ2 test or Fisher’s exact test, unless otherwise stated. *Wilcoxon rank-sum test.